Research

For the benefit of the interested public, researchers, policymakers, and others, relevant research conducted in the state of Connecticut is linked on this page, which is periodically updated as new research becomes available.

Publications

"I think we're getting better but we're still not there": Provider-based stigma and perceived barriers to care for people who use opioids (PWUO).McLean K, Murphy J, Kruis N. J Subst Use Addict Treat. 2024 Apr; 2023 Dec 14. PMID: 38103831.
'Housing First' Increased Psychiatric Care Office Visits And Prescriptions While Reducing Emergency Visits.Hanson D, Gillespie S. Health Aff (Millwood). 2024 Feb; 2024 Jan 24. PMID: 38266198.
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016-17.Heimer R, Black AC, Lin H, Grau LE, Fiellin DA, Howell BA, Hawk K, D'Onofrio G, Becker WC. Drug Alcohol Depend. 2024 Jan 1; 2023 Nov 28. PMID: 38043226.
Overdose Prevention Centers, Crime, and Disorder in New York City.Chalfin A, Del Pozo B, Mitre-Becerril D. JAMA Netw Open. 2023 Nov 1; 2023 Nov 1. PMID: 37955901.
Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration.Quijano T, Crowell J, Eggert K, Clark K, Alexander M, Grau L, Heimer R. Int J Drug Policy. 2023 Oct; 2023 Aug 11. PMID: 37574646.
Prevention of Opioid Use and Disorder Among Youth Involved in the Legal System: Innovation and Implementation of Four Studies Funded by the NIDA HEAL Initiative.Ahrens K, Blackburn N, Aalsma M, Haggerty K, Kelleher K, Knight DK, Joseph E, Mulford C, Ryle T, Tolou-Shams M. Prev Sci. 2023 Oct; 2023 Jul 1. PMID: 37393415.
Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing.Freeman PR, McAninch J, Dasgupta N, Oyler DR, Slavov K, Collins C, Hargrove S, Freeman E, Miracle D, Slavova S. Subst Abuse Treat Prev Policy. 2023 Sep 1; 2023 Sep 1. PMID: 37658455.
Electronic harm reduction interventions for drug overdose monitoring and prevention: A scoping review.Loverock A, Marshall T, Viste D, Safi F, Rioux W, Sedaghat N, Kennedy M, Ghosh SM. Drug Alcohol Depend. 2023 Sep 1; 2023 Jun 30. PMID: 37441959.
Drug Overdose Mortality by Usual Occupation and Industry: 46 U.S. States and New York City, 2020.Billock RM, Steege AL, Miniño A. Natl Vital Stat Rep. 2023 Aug. PMID: 37639452.
Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers.Broady TR, Brener L, Horwitz R, Cama E, Treloar C. Drug Alcohol Depend. 2023 Aug 1; 2023 Jun 2. PMID: 37302358.
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial.Jones CMP, Day RO, Koes BW, Latimer J, Maher CG, McLachlan AJ, Billot L, Shan S, Lin CC. Lancet. 2023 Jul 22; 2023 Jun 28. PMID: 37392748.
Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014-2018.Marotta P, Hass A, Viera A, Doernberg M, Barbour R, Grau LE, Heimer R. Subst Abuse Treat Prev Policy. 2023 Jul 7; 2023 Jul 7. PMID: 37420271.
Civil commitment perspectives and experiences among friends and family of people who use illicit opioids in Massachusetts, USA.Slocum S, Paquette CE, Walley AY, Pollini RA. Int J Drug Policy. 2023 Jul; 2023 May 25. PMID: 37244144.
Overdose Detection Technologies-A New Frontier in Preventing Solitary Drug Overdose Deaths.Park JN, Green TC, Rich JD. JAMA Psychiatry. 2023 Jul 1. PMID: 37099309.
Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US.Weiner SG, Qato DM, Faust JS, Clear B. JAMA Netw Open. 2023 May 1; 2023 May 1. PMID: 37234009.
Substance use disorder bridge clinics: models, evidence, and future directions.Taylor JL, Wakeman SE, Walley AY, Kehoe LG. Addict Sci Clin Pract. 2023 Apr 14; 2023 Apr 14. PMID: 37055851.
Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.D'Onofrio G, Edelman EJ, Hawk KF, Chawarski MC, Pantalon MV, Owens PH, Martel SH, Rothman R, Saheed M, Schwartz RP, Cowan E, Richardson L, Salsitz E, Lyons MS, Freiermuth C, Wilder C, Whiteside L, Tsui JI, Klein JW, Coupet E, O'Connor PG, Matthews AG, Murphy SM, Huntley K, Fiellin DA. JAMA Netw Open. 2023 Apr 3; 2023 Apr 3. PMID: 37017967.
The Nation's First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City.Giglio RE, Mantha S, Harocopos A, Saha N, Reilly J, Cipriano C, Kennelly M, Landau L, McRae M, Chokshi DA. J Urban Health. 2023 Apr; 2023 Apr 4. PMID: 37016269.
Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis.Howell BA, Black AC, Grau LE, Lin HJ, Greene C, Lee H, Heimer R, Hawk KE, D'Onofrio G, Fiellin DA, Becker WC. Drug Alcohol Depend. 2023 Mar 1; 2023 Jan 30. PMID: 36738634.
A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians.Hooker SA, Crain AL, LaFrance AB, Kane S, Fokuo JK, Bart G, Rossom RC. Addict Sci Clin Pract. 2023 Feb 11; 2023 Feb 11. PMID: 36774521.
Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review.Lombardi AR, Arya R, Rosen JG, Thompson E, Welwean R, Tardif J, Rich JD, Park JN. Int J Environ Res Public Health. 2023 Jan 10; 2023 Jan 10. PMID: 36673987.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. MMWR Recomm Rep. 2022 Nov 4; 2022 Nov 4. PMID: 36327391.
Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment.Binswanger IA, Shetterly SM, Xu S, Narwaney KJ, McClure DL, Rinehart DJ, Nguyen AP, Glanz JM. JAMA Netw Open. 2022 Oct 3; 2022 Oct 3. PMID: 36197665.
Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US.Qato DM, Watanabe JH, Clark KJ. JAMA Health Forum. 2022 Aug 5; 2022 Aug 5. PMID: 36218988.
Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy.Larochelle MR, Lodi S, Yan S, Clothier BA, Goldsmith ES, Bohnert ASB. JAMA Netw Open. 2022 Aug 1; 2022 Aug 1. PMID: 35960518.
Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics - 25 States and the District of Columbia, 2019-2020.Kariisa M, Davis NL, Kumar S, Seth P, Mattson CL, Chowdhury F, Jones CM. MMWR Morb Mortal Wkly Rep. 2022 Jul 22; 2022 Jul 22. PMID: 35862289.
2022 Jul 15. PMID: 36260713.
First 2 Months of Operation at First Publicly Recognized Overdose Prevention Centers in US.Harocopos A, Gibson BE, Saha N, McRae MT, See K, Rivera S, Chokshi DA. JAMA Netw Open. 2022 Jul 1; 2022 Jul 1. PMID: 35838672.
Opioid-Related Public Health Communication Campaigns: An Environmental Scan.Frkovich J, Hedrick H, Anakaraonye AR, Bornkessel A, Lefebvre RC. Am J Health Promot. 2022 Jul; 2022 Apr 1. PMID: 35365055.
"You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids.Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. Subst Abuse. 2022; 2022 Jun 27. PMID: 35783464.
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis.Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, Kelly J, Glos L, Eggers SL, Kazemi R, Jalali MS. Sci Adv. 2022 Jun 24; 2022 Jun 24. PMID: 35749492.
What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size.Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerdá M. Drug Alcohol Depend Rep. 2022 Jun; 2022 Apr 8. PMID: 35783994.
Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina.DiPrete BL, Ranapurwala SI, Maierhofer CN, Fulcher N, Chelminski PR, Ringwalt CL, Ives TJ, Dasgupta N, Go VF, Pence BW. JAMA Netw Open. 2022 Apr 1; 2022 Apr 1. PMID: 35476064.
Lessons for the Opioid Crisis-Integrating Social Determinants of Health Into Clinical Care.Hansen H, Jordan A, Plough A, Alegria M, Cunningham C, Ostrovsky A. Am J Public Health. 2022 Apr. PMID: 35349328.
Methadone on Wheels-A New Option to Expand Access to Care Through Mobile Units.Gibbons JB, Stuart EA, Saloner B. JAMA Psychiatry. 2022 Mar 1. PMID: 35019950.
Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Care Professionals: A Randomized Clinical Trial.Kennedy-Hendricks A, McGinty EE, Summers A, Krenn S, Fingerhood MI, Barry CL. JAMA Netw Open. 2022 Feb 1; 2022 Feb 1. PMID: 35119460.
The Stigma of Criminal Legal Involvement and Health: a Conceptual Framework.Howell BA, Earnshaw VA, Garcia M, Taylor A, Martin K, Fox AD. J Urban Health. 2022 Feb; 2022 Jan 15. PMID: 35031942.
Change in Per Capita Opioid Prescriptions Filled at Retail Pharmacies, 2008-2009 to 2017-2018.Stein BD, Taylor EA, Sheng F, Dick AW, Vaiana M, Sorbero M. Ann Intern Med. 2022 Feb; 2021 Dec 28. PMID: 34958601.
Changes in methadone take-home dosing before and after COVID-19.Amram O, Amiri S, Thorn EL, Lutz R, Joudrey PJ. J Subst Abuse Treat. 2022 Feb; 2021 Jun 24. PMID: 34304950.
Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.Wu LT, John WS, Morse ED, Adkins S, Pippin J, Brooner RK, Schwartz RP. Addiction. 2022 Feb; 2021 Aug 16. PMID: 34286886.
Overdose and Homelessness-Why We Need to Talk About Housing.Doran KM, Fockele CE, Maguire M. JAMA Netw Open. 2022 Jan 4; 2022 Jan 4. PMID: 34994799.
The Role of Misinformation and Stigma in Opioid Use Disorder Treatment Uptake.Garett R, Young SD. Subst Use Misuse. 2022; 2022 May 25. PMID: 35611913.
Multisystemic Therapy - Building Stronger Families (MST-BSF): Substance misuse, child neglect, and parenting outcomes from an 18-month randomized effectiveness trial.Schaeffer CM, Swenson CC, Powell JS. Child Abuse Negl. 2021 Dec; 2021 Nov 3. PMID: 34742002.
Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program.Snyder H, Kalmin MM, Moulin A, Campbell A, Goodman-Meza D, Padwa H, Clayton S, Speener M, Shoptaw S, Herring AA. Ann Emerg Med. 2021 Dec; 2021 Aug 2. PMID: 34353655.
A systematic review of stigma interventions for providers who treat patients with substance use disorders.Bielenberg J, Swisher G, Lembke A, Haug NA. J Subst Abuse Treat. 2021 Dec; 2021 May 25. PMID: 34217033.
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.Brothers S, Viera A, Heimer R. J Subst Abuse Treat. 2021 Dec; 2021 Apr 29. PMID: 34098303.
Outcomes associated with the use of medications for opioid use disorder during pregnancy.Krans EE, Kim JY, Chen Q, Rothenberger SD, James AE 3rd, Kelley D, Jarlenski MP. Addiction. 2021 Dec; 2021 Jun 9. PMID: 34033170.
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.Amram O, Amiri S, Panwala V, Lutz R, Joudrey PJ, Socias E. Am J Drug Alcohol Abuse. 2021 Nov 2; 2021 Oct 20. PMID: 34670453.
Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis.Rao IJ, Humphreys K, Brandeau ML. Lancet Reg Health Am. 2021 Nov; 2021 Jul 31. PMID: 34790907.
Using Surveillance With Near-Real-Time Alerts During a Cluster of Overdoses From Fentanyl-Contaminated Crack Cocaine, Connecticut, June 2019.Canning P, Doyon S, Ali S, Logan SB, Alter A, Hart K, Coler R, Kamin R, Wolf SC, Soto K, Whiteman L, Jenkins M. Public Health Rep. 2021 Nov-Dec. PMID: 34726975.
Opioid Overdose Surveillance : Improving Data to Inform Action.Hoots BE. Public Health Rep. 2021 Nov-Dec. PMID: 34726970.
Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories.Cabreros I, Griffin BA, Saloner B, Gordon AJ, Kerber R, Stein BD. Drug Alcohol Depend. 2021 Nov 1; 2021 Sep 22. PMID: 34600259.
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.Zhu Y, Mooney LJ, Yoo C, Evans EA, Kelleghan A, Saxon AJ, Curtis ME, Hser YI. Drug Alcohol Depend. 2021 Nov 1; 2021 Aug 28. PMID: 34555691.
Supervised Injection Facilities as Harm Reduction: A Systematic Review.Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, Bazzi AR. Am J Prev Med. 2021 Nov; 2021 Jul 1. PMID: 34218964.
Implementing the Street Psychiatry Model in New Haven, CT: Community-Based Care for People Experiencing Unsheltered Homelessness.Lo E, Lifland B, Buelt EC, Balasuriya L, Steiner JL. Community Ment Health J. 2021 Nov; 2021 May 31. PMID: 34059983.
Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis.Vo AT, Magana C, Hickman M, Borquez A, Beletsky L, Martin NK, Cepeda JA. Int J Drug Policy. 2021 Oct; 2021 Aug 11. PMID: 34389218.
Post-incarceration outcomes for individuals who continued methadone treatment while in Connecticut jails, 2014-2018.Haas A, Viera A, Doernberg M, Barbour R, Tong G, Grau LE, Heimer R. Drug Alcohol Depend. 2021 Oct 1; 2021 Jul 28. PMID: 34371235.
Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis.Bolívar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. JAMA Psychiatry. 2021 Oct 1. PMID: 34347030.
Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.McCarty D, Bougatsos C, Chan B, Hoffman KA, Priest KC, Grusing S, Chou R. Am J Psychiatry. 2021 Sep 1; 2021 Jul 28. PMID: 34315284.
Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department.Hawk K, Hoppe J, Ketcham E, LaPietra A, Moulin A, Nelson L, Schwarz E, Shahid S, Stader D, Wilson MP, D'Onofrio G. Ann Emerg Med. 2021 Sep; 2021 Jun 23. PMID: 34172303.
Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids.Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. JAMA. 2021 Aug 3. PMID: 34342618.
Interim methadone - Effective but underutilized: A scoping review.McCarty D, Chan B, Bougatsos C, Grusing S, Chou R. Drug Alcohol Depend. 2021 Aug 1; 2021 May 21. PMID: 34051546.
Dental Opioid Prescriptions and Overdose Risk in Patients and Their Families.Chua KP, Kenney BC, Waljee JF, Brummett CM, Nalliah RP. Am J Prev Med. 2021 Aug; 2021 Apr 29. PMID: 33975766.
Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden.Kazerouni NJ, Irwin AN, Levander XA, Geddes J, Johnston K, Gostanian CJ, Mayfield BS, Montgomery BT, Graalum DC, Hartung DM. Drug Alcohol Depend. 2021 Jul 1; 2021 Apr 24. PMID: 33932744.
Cost-effectiveness of Treatments for Opioid Use Disorder.Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. JAMA Psychiatry. 2021 Jul 1. PMID: 33787832.
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017.Schuler MS, Dick AW, Stein BD. Drug Alcohol Depend. 2021 Jun 1; 2021 Apr 20. PMID: 33873027.
Risk of overdose-related death for people with a history of incarceration.Gan WQ, Kinner SA, Nicholls TL, Xavier CG, Urbanoski K, Greiner L, Buxton JA, Martin RE, McLeod KE, Samji H, Nolan S, Meilleur L, Desai R, Sabeti S, Slaunwhite AK. Addiction. 2021 Jun; 2020 Nov 27. PMID: 33047844.
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19.Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. J Subst Abuse Treat. 2021 Apr; 2021 Jan 8. PMID: 33612201.
Medication for Adolescents and Young Adults With Opioid Use Disorder.J Adolesc Health. 2021 Mar; 2021 Jan 21. PMID: 33485735.
Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of Two Different Drug Analysis Methodologies.Fregonese M, Albino A, Covino C, Gili A, Bacci M, Nicoletti A, Gambelunghe C. Front Psychiatry. 2021; 2021 Feb 22. PMID: 33692707.
Projected Estimates of Opioid Mortality After Community-Level Interventions.Linas BP, Savinkina A, Madushani RWMA, Wang J, Eftekhari Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA. JAMA Netw Open. 2021 Feb 1; 2021 Feb 1. PMID: 33587136.
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose.Becker WC, Heimer R, Dormitzer CM, Doernberg M, D'Onofrio G, Grau LE, Hawk K, Lin HJ, Secora AM, Fiellin DA. Addict Sci Clin Pract. 2021 Jan 4; 2021 Jan 4. PMID: 33397480.
Program development and implementation outcomes of a statewide addiction consultation service: Maryland Addiction Consultation Service (MACS).Sweeney S, Coble K, Connors E, Rebbert-Franklin K, Welsh C, Weintraub E. Subst Abus. 2021; 2020 Aug 19. PMID: 32814004.
Drug Checking and Its Potential Impact on Substance Use.Betzler F, Helbig J, Viohl L, Ernst F, Roediger L, Gutwinski S, Ströhle A, Köhler S. Eur Addict Res. 2021; 2020 Jun 12. PMID: 32535605.
Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study.Lefebvre RC, Chandler RK, Helme DW, Kerner R, Mann S, Stein MD, Reynolds J, Slater MD, Anakaraonye AR, Beard D, Burrus O, Frkovich J, Hedrick H, Lewis N, Rodgers E. Drug Alcohol Depend. 2020 Dec 1; 2020 Oct 5. PMID: 33152673.
Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.Martin A, Butler K, Chavez T, Herring A, Wakeman S, Hayes BD, Raja A. West J Emerg Med. 2020 Nov 2; 2020 Nov 2. PMID: 33207174.
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.Ballreich J, Mansour O, Hu E, Chingcuanco F, Pollack HA, Dowdy DW, Alexander GC. JAMA Netw Open. 2020 Nov 2; 2020 Nov 2. PMID: 33146732.
Methadone for Opioid Use Disorder-Decades of Effectiveness but Still Miles Away in the US.Joudrey PJ, Edelman EJ, Wang EA. JAMA Psychiatry. 2020 Nov 1. PMID: 32667643.
Is the Housing First Model Effective? Different Evidence for Different Outcomes.Tsai J. Am J Public Health. 2020 Sep. PMID: 32783738.
Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. J Gen Intern Med. 2020 Sep; 2020 Jun 24. PMID: 32583337.
The relationship between incarceration history and overdose in North America: A scoping review of the evidence.Mital S, Wolff J, Carroll JJ. Drug Alcohol Depend. 2020 Aug 1; 2020 May 24. PMID: 32498032.
Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.Walley AY, Lodi S, Li Y, Bernson D, Babakhanlou-Chase H, Land T, Larochelle MR. Addiction. 2020 Aug; 2020 Feb 25. PMID: 32096908.
One million screened: Scaling up SBIRT and buprenorphine treatment in hospital emergency departments across Maryland.Monico LB, Oros M, Smith S, Mitchell SG, Gryczynski J, Schwartz R. Am J Emerg Med. 2020 Jul; 2020 Mar 6. PMID: 32171581.
Stigma Reduction to Combat the Addiction Crisis - Developing an Evidence Base.McGinty EE, Barry CL. N Engl J Med. 2020 Apr 2. PMID: 32242352.
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.Goedel WC, Shapiro A, Cerdá M, Tsai JW, Hadland SE, Marshall BDL. JAMA Netw Open. 2020 Apr 1; 2020 Apr 1. PMID: 32320038.
Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation.Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, Robinson A, Paik M, Sandbrink F, Gordon AJ, Trafton JA. BMJ. 2020 Mar 4; 2020 Mar 4. PMID: 32131996.
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.J Addict Med. 2020 Mar/Apr. PMID: 32511106.
Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review.Bonar EE, Coughlin L, Roche JS, Philyaw-Kotov ML, Bixler EA, Sinelnikov S, Kolosh A, Cihak MJ, Cunningham RM, Walton MA. Prev Med. 2020 Mar; 2020 Jan 3. PMID: 31904397.
Defining Low-threshold Buprenorphine Treatment.Jakubowski A, Fox A. J Addict Med. 2020 Mar/Apr. PMID: 31567596.
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. JAMA Netw Open. 2020 Feb 5; 2020 Feb 5. PMID: 32022884.
Opioid use disorder.Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh SL. Nat Rev Dis Primers. 2020 Jan 9; 2020 Jan 9. PMID: 31919349.
Racial/Ethnic Differences in Drug- and Alcohol-Related Arrest Outcomes in a Southwest County From 2009 to 2018.Camplain R, Camplain C, Trotter RT 2nd, Pro G, Sabo S, Eaves E, Peoples M, Baldwin JA. Am J Public Health. 2020 Jan. PMID: 31967892.
Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study.Krawczyk N, Eisenberg M, Schneider KE, Richards TM, Lyons BC, Jackson K, Ferris L, Weiner JP, Saloner B. Ann Emerg Med. 2020 Jan; 2019 Sep 9. PMID: 31515181.
Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA.Bessen S, Metcalf SA, Saunders EC, Moore SK, Meier A, McLeman B, Walsh O, Marsch LA. Int J Drug Policy. 2019 Dec; 2019 Oct 4. PMID: 31590090.
Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study.Larochelle MR, Bernstein R, Bernson D, Land T, Stopka TJ, Rose AJ, Bharel M, Liebschutz JM, Walley AY. Drug Alcohol Depend. 2019 Nov 1; 2019 Sep 3. PMID: 31521956.
Rate of Opioid Prescriptions for Patients With Acute Ankle Sprain.Finney FT, Gossett TD, Hu HM, Waljee JF, Brummett CM, Walton DM, Talusan PG, Holmes JR. Ann Intern Med. 2019 Sep 17; 2019 Jul 9. PMID: 31284299.
Buprenorphine Treatment Divide by Race/Ethnicity and Payment.Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. JAMA Psychiatry. 2019 Sep 1. PMID: 31066881.
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.Ciccarone D. Int J Drug Policy. 2019 Sep; 2019 Feb 2. PMID: 30718120.
Intervention stigma: How medication-assisted treatment marginalizes patients and providers.Madden EF. Soc Sci Med. 2019 Jul; 2019 May 17. PMID: 31125801.
Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis.Compton WM, Jones CM, Baldwin GT, Harding FM, Blanco C, Wargo EM. Am J Public Health. 2019 Jun. PMID: 31242006.

Additional Publications

Bonnevie E, Kaynak Ö, Whipple CR, Kensinger WS, Stefanko M, McKeon C, Mendell G, Smyser J. Life unites us: A novel approach to addressing opioid use disorder stigma. Health Education Journal. 2022;81(3):312-324.

Jackson JR, Harle CA, Silverman RD, Simon K, Menachemi N. Characterizing variability in state-level regulations governing opioid treatment programs. Journal of Substance Abuse Treatment. 2020;115(108008).

Kirk DS, Wakefield S. Collateral consequences of punishment: A critical review and path forward. Review of Criminology 2018;1:171-194.

Montgomery AE HL, Kane V, Culhane DP. Housing chronically homeless veterans: Evaluating the efficacy of a Housing First approach to HUD-VASH. Journal of Community Psychology. 2013;41(4): 505-514.

Ramos C, Clemans-Cope L, Samuel-Jakubos H, Basurto L. Evidence-Based Interventions for Adolescent Opioid Use Disorder: What Might Work for High-Risk Ohio Counties? Washington, DC.: Urban Institute; 2018.